ANIP - ANI Pharmaceuticals Inc Net earnings per share (EPS TTM)

Symbol and logo of brand ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals is expanding its portfolio through licensing agreements and contract outsourcing. The rolling annual EPS trend confirms this momentum, with the latest value recorded as 4.98. Business stability is underpinned by the production of generics and the premium Cortrophin Gel. Risks are minimized through the localization of raw materials, which protects the company from external geopolitical shocks.

ANIP (ANI Pharmaceuticals) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/14/2026

Summary analytical data breakdowns for ANI Pharmaceuticals Corp (ANIP)

- share price and expert price forecast:
Stock Quotes ANI Pharmaceuticals|ANIP - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization ANI Pharmaceuticals Corp|ANIP - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share ANI Pharmaceuticals|ANIP - Total Stockholders' Equity|Market Value to Book Value Ratio anipharmaceuticals.com|ANIP - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital ANI Pharmaceuticals|ANIP - Long-Term Debt to Capital|Short-Term Debt to Equity ANI Pharmaceuticals, Inc.|ANIP - Company Aggregate Debt|Debts to Book Capitalization ANI Pharmaceuticals|ANIP - Long-Term Debt Volume|Company Current Liabilities ANI Pharmaceuticals|Quick Liquidity anipharmaceuticals.com
- net income and valuation multiples indicators:
ANIP - Profit After Tax|Projected Future Earnings ANI Pharmaceuticals|ANIP - Company Value to Net Income|Forward P/E Multiple ANI Pharmaceuticals Inc|ANIP - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ANI Pharmaceuticals Corp|ANIP - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months ANI Pharmaceuticals|ANIP - Net earnings per share for the last 12 months|Quarterly EPS earnings growth anipharmaceuticals.com|ANIP - Earnings growth in current year|Earnings growth forecast for next year ANI Pharmaceuticals
- revenue and sales proceeds data:
ANIP - Company Sales|Projected Sales Volume ANI Pharmaceuticals Corp|ANIP - Price to Sales|Forward Price-to-Revenue Multiple ANI Pharmaceuticals Inc
Fundamental valuation:ANI Pharmaceuticals Inc (ANIP)
Manufactured products of ANI Pharma

This indicator serves as a critical filter during asset stress testing, allowing for the exclusion of overvalued companies facing excessive debt pressure. The metric calculates annual net income per common share, which, in a rolling earnings per share figure, reflects the actual efficiency of the compact development team at ANI Pharmaceuticals (ANIP), whose high decision-making speed converts directly into profit growth.

Competitors of ANI Pharmaceuticals

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|Afrezza - Net earnings per share (EPS TTM)|amphastar.com (AMPH) - Net earnings per share for the last 12 months|PCRX: Net earnings per share (EPS TTM)|SPRY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Theravance|Net earnings per one share for the last twelve months Aquestive Corp AQST|Net earnings per share (EPS TTM) SCPH|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP